Tsuchimoto Kim R: insider trades.
Tsuchimoto Kim R reported 14 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 12 sales ($911K), across 1 company.
- Transactions
- 14
- Purchases (P)
- 0
- Sales (S)
- 12
- Companies
- 1
- Name as filed
- Tsuchimoto Kim R
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Monopar Therapeutics (MNPR) | Director | 14 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-26 | Monopar Therapeutics | S | 700 | $110.65 | 2,290 | Form 4/A |
| 2026-08-26 | Monopar Therapeutics | S | 602 | $112.93 | 590 | Form 4/A |
| 2026-08-26 | Monopar Therapeutics | S | 590 | $113.84 | 0 | Form 4/A |
| 2026-08-26 | Monopar Therapeutics | S | 615 | $109.56 | 2,990 | Form 4/A |
| 2026-08-26 | Monopar Therapeutics | S | 485 | $108.83 | 3,605 | Form 4/A |
| 2026-08-26 | Monopar Therapeutics | M | 2,035 | $14 | 4,090 | Form 4/A |
| 2026-08-26 | Monopar Therapeutics | M | 2,055 | $30 | 2,055 | Form 4/A |
| 2026-08-26 | Monopar Therapeutics | S | 1,098 | $111.84 | 1,192 | Form 4/A |
| 2026-08-26 | Monopar Therapeutics | S | 602 | $112.93 | 7,986 | Form 4 |
| 2026-08-26 | Monopar Therapeutics | S | 1,098 | $111.84 | 8,588 | Form 4 |
| 2026-08-26 | Monopar Therapeutics | S | 700 | $110.65 | 9,686 | Form 4 |
| 2026-08-26 | Monopar Therapeutics | S | 615 | $109.56 | 10,386 | Form 4 |
| 2026-08-26 | Monopar Therapeutics | S | 590 | $113.84 | 7,396 | Form 4 |
| 2026-08-26 | Monopar Therapeutics | S | 485 | $108.83 | 11,001 | Form 4 |
Questions
What stock did Tsuchimoto Kim R buy or sell?
Tsuchimoto Kim R reported 14 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 12 sales ($911K), across 1 company.
Is Tsuchimoto Kim R the same person as other filers with this name?
This page covers SEC CIK 1333516 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/tsuchimoto-kim-r-1333516.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.